Microvessel density of hepatocellular carcinoma: its relationship with prognosis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  1999-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004320050296PMID 10394963PMCID PMC12199822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry.

  2008cited by this paper
• Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype

  2005cited by this paper
• Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma

  1999cited by this paper
• Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.

  1998cited by this paper
• Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver

  1998cited by this paper
• Tumor angiogenesis and mode of metastasis in patients with colorectal cancer.

  1997influential reference
• Microvessel count predicts metastasis and prognosis in patients with gastric cancer

  1997cited by this paper
• Quantitation of sinusoid‐like vessels in hepatocellular carcinoma: Its clinical and prognostic significance

  1997influential reference
• Three decades' experience in surgery of hepatocellular carcinoma.

  1997cited by this paper
• Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma

  1997influential reference
• Prognostic influence of clinicopathologic features, DNA‐ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in france

  1997cited by this paper
• Prognostic factors affecting long-term survival after partial hepatectomy for human hepatocellular carcinoma.

  1997cited by this paper
• Significance of alpha‐fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection

  1997cited by this paper
• Clinicopathologic factors influencing the long-term prognosis following hepatic resection for large hepatocellular carcinoma more than 10 cm in diameter.

  1997cited by this paper
• Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.

  1996cited by this paper
• Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma.

  1996influential reference
• DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver.

  1996cited by this paper
• Enhanced CD34 expression of sinusaid‐like vascular endothelial cells in hepatocellular carcinoma

  1996cited by this paper
• Immunoreactivity of sinusoids in hepatoblastoma: an immunohistochemical study using lectin UEA‐1 and antibodies against endothelium‐associated antigens, including CD34

  1995cited by this paper
• Tumor angiogenesis in advanced stage ovarian carcinoma.

  1995influential reference
• Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.

  1995cited by this paper
• Secondary prevention of hepatocellular carcinoma

  1995cited by this paper
• Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma.

  1994influential reference
• Sinusoidal capillarization in small hepatocellular carcinoma

  1994cited by this paper
• Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

  1993influential reference
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.

  1992cited by this paper
• Resection of hepatocellular carcinoma: Oligocentric origin of recurrent and multinodular tumours

  1991cited by this paper
• Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.

  1991cited by this paper
• Expression of ABH blood group antigens, Ulex europaeus agglutinin I, and type IV collagen in the sinusoids of hepatocellular carcinoma.

  1991cited by this paper
• Tumor angiogenesis.

  1974cited by this paper

• The prognostic role of Angiogenesis, Lymphangiogenesis and Vasculogenic mimicry in Hepatocellular Carcinomas treated with Transplantation

  2025cites this paper
• Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment

  2024cites this paper
• Perfusion of hepatocellular carcinomas measured by diffusion‐derived vessel density biomarker: Higher hepatocellular carcinoma perfusion than earlier intravoxel incoherent motion reports

  2024cites this paper
• Effects of human amniotic membrane on the angiogenesis and healing of ischemic wounds in a rat model

  2024cites this paper
• Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery.

  2024cites this paper
• GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments

  2021cites this paper
• Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan

  2021cites this paper
• Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas

  2020cites this paper
• Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma

  2019influential citation
• Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study

  2019cites this paper
• Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib.

  2019cites this paper
• Targeted agents for second-line treatment of advanced hepatocellular carcinoma

  2019cites this paper
• Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC

  2019cites this paper
• High-resolution 3D fluorescent imaging of intact tissues

  2019cites this paper
• Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses

  2017cites this paper
• The association between aquaporin-1 expression, microvessel density and the clinicopathological features of hepatocellular carcinoma

  2017cites this paper
• Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.

  2017cites this paper
• Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma

  2017cites this paper
• Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma

  2017cites this paper
• Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.

  2017cites this paper
• Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology

  2016cites this paper
• Title An Immunohistochemical Study of Tumor Vascularity and Proliferation Activity in Cholangiocellular Carcinoma : Relationship to Clinicopathologic Factors and Prognosis after Hepatic Resection

  2016cites this paper
• Cancer Patient–Derived Circulating Microparticles Enhance Lung Metastasis in a Rat Model: Dual-Source CT, Cellular, and Molecular Studies

  2016cites this paper
• Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma

  2016cites this paper
• FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis

  2016cites this paper
• Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1.

  2016cites this paper
• Absence of CD66a expression is associated with high microvessel density and high histologic grade in hepatocellular carcinoma

  2016cites this paper
• [Vascularization of hepatoceliular carcinoma].

  2015cites this paper
• A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice

  2015cites this paper
• Biology of Hepatocellular Carcinoma

  2015cites this paper
• Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.

  2015cites this paper
• Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work

  2015cites this paper
• Prognostic Value of Microvessel Density in Hepatocellular Carcinoma Patients: A Meta-Analysis

  2014cites this paper
• An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.

  2014influential citation
• The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.

  2014cites this paper
• Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent

  2014cites this paper
• The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

  2014cites this paper
• Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

  2013cites this paper
• Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma.

  2013cites this paper
• Diagnostic Value of Immunohistochemical Staining of GP73, GPC3, DCP, CD34, CD31, and Reticulin Staining in Hepatocellular Carcinoma

  2013cites this paper
• Prognostic Roles of Cross-Talk between Peritumoral Hepatocytes and Stromal Cells in Hepatocellular Carcinoma Involving Peritumoral VEGF-C, VEGFR-1 and VEGFR-3

  2013cites this paper
• Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer

  2013cites this paper
• Predictive Biomarkers of Antiangiogenic Therapy for Advanced Hepatocellular Carcinoma: Where Are We?

  2013cites this paper
• Biomarkers of Hepatocellular Carcinoma

  2012cites this paper
• Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy.

  2012cites this paper
• Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma

  2012cites this paper
• High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma

  2012cites this paper
• Esophageal Squamous Cell Carcinoma: Assessing Tumor Angiogenesis Using Multi-Slice CT Perfusion Imaging

  2012cites this paper
• The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

  2011cites this paper
• Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis

  2011cites this paper
• CEACAM1 Cytoplastic Expression is Closely Related to Tumor Angiogenesis and Poorer Relapse-free Survival After Curative Resection of Hepatocellular Carcinoma

  2011cites this paper
• Morphologic classification of microvessels in hepatocellular carcinoma is associated with the prognosis after resection

  2011cites this paper
• Clinical significance and implication of neoangiogenesis in hepatocellular carcinoma

  2011cites this paper
• Down-regulation of artery in moderately differentiated hepatocellular carcinoma related to tumor development.

  2010cites this paper
• High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients.

  2010cites this paper
• The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.

  2010cites this paper
• High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

  2010cites this paper
• Molecular Events on Metastasis of Hepatocellular Carcinoma

  2010cites this paper
• Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics

  2010cites this paper
• Elevated renin levels in patients with liver cirrhosis and hepatocellular carcinoma.

  2010cites this paper
• Expression and correlation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis.

  2009cites this paper
• Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival

  2009cites this paper
• A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.

  2009cites this paper
• Angiogenesis in human liver tumors

  2009cites this paper
• Tumor Markers and Molecular Biology

  2009cites this paper
• The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus

  2009cites this paper
• Expression and Correlation of Hypoxia-inducible Factor-1α, Vascular Endothelial Growth Factor and Microvessel Density in Experimental Rat Hepatocarcinogenesis

  2009cites this paper
• Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients

  2008cites this paper
• Biology of Hepatocellular Carcinoma

  2008cites this paper
• Gene analysis of free fetal DNA in maternal plasma

  2008cites this paper
• New strategy of antiangiogenic therapy for hepatocellular carcinoma.

  2008cites this paper
• Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma.

  2008influential citation
• Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.

  2008cites this paper
• Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization

  2008cites this paper
• Vascular Changes in Hepatocellular Carcinoma

  2008cites this paper
• High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies

  2007cites this paper
• Prognostic molecular markers in hepatocellular carcinoma: a systematic review.

  2007cites this paper
• Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

  2007cites this paper
• From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now

  2007cites this paper
• Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis

  2007cites this paper
• Clinical aspects of natural anti-angiogenic drugs.

  2006cites this paper
• Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.

  2006cites this paper
• CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients

  2006cites this paper
• Focal liver lesions: sinusoidal phase of CEUS

  2006cites this paper
• Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma.

  2005cites this paper
• RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.

  2005cites this paper
• Metastasis and Recurrence After Surgical Resection of Hepatocellular Carcinoma: Recent Progress in Clinical and Related Basic Aspects

  2005influential citation
• Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue.

  2005cites this paper
• Correlative study of angiogenesis and dynamic contrast‐enhanced magnetic resonance imaging features of hepatocellular carcinoma

  2005cites this paper
• Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential

  2005cites this paper
• Hypoechoic focal liver lesions: Characterization with contrast enhanced ultrasonography

  2005cites this paper
• Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection

  2004cites this paper
• Immunohistochemical and Molecular Markers in the Diagnosis of Hepatocellular Carcinoma

  2004cites this paper
• Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature

  2004cites this paper
• Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

  2004cites this paper
• Are tumours angiogenesis‐dependent?

  2004cites this paper
• Angiogenesis and hepatocellular carcinoma.

  2004cites this paper
• Novel endothelial cell markers in hepatocellular carcinoma

  2004cites this paper
• Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis

  2004cites this paper
• Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

  2004cites this paper